INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Organon & Co. of Class Action Lawsuit and Upcoming Deadlines - OGN

Core Viewpoint - A class action lawsuit has been filed against Organon & Co. regarding allegations of securities fraud and unlawful business practices [2][3]. Group 1: Lawsuit Details - The lawsuit involves claims that Organon and certain officers and/or directors engaged in securities fraud or other unlawful business practices [2]. - Investors have until July 22, 2025, to request to be appointed as Lead Plaintiff if they purchased Organon securities during the Class Period [2]. Group 2: Financial Performance - On May 1, 2025, Organon reported a significant reduction in its dividend payout from $0.28 to $0.02, which was attributed to a strategic decision to prioritize capital allocation towards deleveraging [3]. - Following the announcement of the dividend cut, Organon's stock price dropped by $3.48 per share, or 26.91%, closing at $9.45 per share on the same day [3].